The global cell sorting market size was valued at USD 405.47 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of10.5% from 2019 to 2026. Growing research in cell sorting technologies, technological advancements in cell sorters, and rising pharmaceutical & biotechnology companies are expected to drive growth.
Growing R&D investments by pharmaceutical and biotechnology companies have led to significant growth in the market. Initiatives in developing novel therapeutics are expected to increase research activities through cell sorting. Increasing disease prevalence and the geriatric population are also some of the significant factors fostering the growth of pharma and biotech companies.
Flow cytometry-based sorting has been widely used by researchers in biology laboratories for cell isolation. Significant technological advancements have been observed in this field. In the journal Cell, in August 2018, researchers announced the development of Image-Activated Cell Sorting (IACS). This instrument integrates microfluidic, optical, computational, electrical, and mechanical technologies for sorting cells on the basis of their global phenotypic profiles and morphological & spatial properties, using an image-driven approach. The technique helps view cell pictures in 2D by stacking the 1D spatial profiles after demodulating the detected transmission and fluorescence signals.
Cell sorting using microfluidic technology is growing significantly due to its convenient and fast application as well as lower costs as compared to other techniques such as FACS and MACS. Due to the non-magnetic cell sorting technology, instruments with microfluidic technology speed up the process, sorting billions of cells per second.
Growing prevalence of HIV and cancer is also driving the market. Flow cytometry-based assay help quantifies and characterizes infected cells in HIV patients. Over the years, cell sorting was combined with molecular biological techniques and proteomics for characterizing metastatic & primary cancer cell populations and single tumor cells.
The market is segmented into cell sorters, services, and reagents & consumables. Cell sorters dominated the market in 2018, owing to their advanced technology. The introduction of novel instruments has eased the sorting procedure and led to faster results. These machines are very expensive, costing around USD 150,000, which can be attributed to the segment’s high share.
Reagents and consumables also held a significant share in 2018 owing to the wide applications of these products. With increasing applications of sorting technologies, cell labeling reagents have become widely available in the market. Services segment is expected to exhibit significant growth over the forecast period, owing to the presence of a large number of academic institutes conducting cell-based research.
On the basis of technology, Fluorescence-based Droplet Cell Sorting (FACS) segment generated the highest revenue in 2018, as it is a highly accurate and precise sorting method. However, the machines based on this technology is very expensive and require skilled professionals to operate. This factor can hinder growth of this technology when compared to magnetic-activated cell sorting.
Microfluidics segment is expected to show lucrative CAGR over the forecast period due to its faster output. It enables 99% cell purity and cell output of 48,000/s. Introduction of novel products in this field is also generating high demand for this technology. In addition, microfluidic-based instruments are less expensive as compared to FACS, which is further driving the segment growth.
Among the application segment, research applications held the largest market share in 2018. This can be attributed to the growing cellular analysis in the field of cancer, stem cells, drug discovery, protein engineering, and cell engineering. Flow cytometry-based sorting plays a significant role in the development of therapeutic products due to its ability to analyze heterogeneous cell populations.
Clinical applications are anticipated to show lucrative growth over the forecast period due to the rising prevalence of diseases, such as HIV and cancer. According to researchers, a novel product based on microfluidic technique facilitates separation of circulating tumor cells from the peripheral blood of patients suffering from cancer. Cell-by-Cell Morpho-rheological (MORE) analysis helps in identifying major blood cells as well as characterizing their pathological changes during diseases in vitro & in vivo.
On the basis of end-use, research institutions accounted for the largest share of cell sorting market in 2018, owing to the rising number of research activities in cellular analysis. Rise in the number of cell-based therapies and applications is also driving segment growth. Increasing investments in cancer and stem cell research are also aiding growth.
Medical schools and academic institutions are anticipated to witness a significant CAGR during the forecast period. Rising collaborations between academic institutions and pharma & biotech companies have led to growth in the number of research activities. In addition, outsourcing of cellular analyses from these academic institutes enables rapid production process for pharma & biotech companies.
North America dominated the market in 2018 due to high investments in pharmaceutical & biotechnology industries and increasing adoption of this technique in cancer research, as well as development of new therapeutics in countries such as the U.S. In addition, rising incidence of cancer in the U.S. drives regional growth. Moreover, advancements in sorting instruments have led to high demand for these products in the region.
Asia Pacific region is expected to witness lucrative growth over the forecast period, owing to rising prevalence of HIV and cancer. According to WHO, as per 2018 statistics, the incidence of cancer in Asia was 48.4% of that of the global incidence. Moreover, booming biotechnology and pharmaceutical industries in countries such as India are expected to boost regional growth.
Key companies are engaged in significant strategic initiatives such as regional expansion, product development, and strategic collaborations & partnerships. For instance, in 2018, Becton, Dickinson and Company introduced its new BD FACSymphony S6 cell sorter in order to provide a better cell population sorting to analyze cell phenotypes for multiomics and immunology research purposes. Some of the prominent players in the cell sorting market include:
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc.
Sony Biotechnology Inc.
Miltenyi Biotec GmbH
On-Chip Biotechnologies Co., Ltd.
Cytonome/St, LLC
Union Biometrica, Inc.
Thermo Fisher Scientific, Inc.
Report Attribute |
Details |
Market size value in 2020 |
USD 492.2 million |
Revenue forecast in 2026 |
USD 899.4 million |
Growth Rate |
CAGR of 10.5% from 2019 to 2026 |
Base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, technology, application, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Japan; India; China; South Korea; Singapore; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; Beckman Coulter, Inc.; Sony Biotechnology Inc.; Miltenyi Biotec GmbH; On-Chip Biotechnologies Co., Ltd.; Cytonome/St, LLC; Union Biometrica, Inc.; Thermo Fisher Scientific, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, & country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global cell sorting market report on the basis of product, technology, application, end-use, and region:
Product Type Outlook (Revenue, USD Million, 2015 - 2026)
Cell Sorters
Reagents and Consumables
Services
Technology Outlook (Revenue, USD Million, 2015 - 2026)
Fluorescence-based Droplet Cell Sorting
Jet-in-air Cell Sorting
Cuvette-based Cell Sorting
Magnetic-activated Cell Sorting
MEMS - Microfluidics
Application Outlook (Revenue, USD Million, 2015 - 2026)
Research Applications
Immunology & Cancer Research
Stem Cell Research
Drug Discovery
Other Research Applications
Clinical Applications
End-use Outlook (Revenue, USD Million, 2015 - 2026)
Research Institutions
Medical Schools and Academic Institutions
Pharmaceutical and Biotechnology Companies
Hospitals and Clinical Testing Laboratories
Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
Germany
The U.K.
France
Italy
Spain
Russia
Asia Pacific
Japan
China
India
South Korea
Australia
Singapore
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
b. The global cell sorting market size was estimated at USD 446.6 million in 2019 and is expected to reach USD 492.2 million in 2020.
b. The global cell sorting market is expected to grow at a compound annual growth rate of 10.5% from 2019 to 2026 to reach USD 899.4 million by 2026.
b. North America dominated the cell sorting market with a share of 38.4% in 2019. This is attributable to high investments in pharmaceutical & biotechnology industries and increasing adoption of this technique in cancer research, as well as development of new therapeutics in countries such as the U.S.
b. Some key players operating in the cell sorting market include Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; Beckman Coulter, Inc.; Sony Biotechnology Inc.; Miltenyi Biotec GmbH; On-Chip Biotechnologies Co., Ltd.; Cytonome/St, LLC; Union Biometrica, Inc.; and Thermo Fisher Scientific, Inc.
b. Key factors that are driving the market growth include Growing research in cell sorting technologies, technological advancements in cell sorters, and rising pharmaceutical & biotechnology companies.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.